Publications by authors named "Ada Maria de Barcelos Alves"

Dengue disease is an acute viral illness caused by dengue virus (DENV) that can progress to hemorrhagic stages leading to about 20000 deaths every year worldwide. Despite many clinical investigations regarding dengue, the immunopathogenic process by which infected patients evolve to the severe forms is not fully understood. Apart from differences in virulence and the antibody cross reactivity that can potentially augment virus replication, imbalanced cellular immunity is also seen as a major concern in the establishment of severe dengue.

View Article and Find Full Text PDF
Article Synopsis
  • Dengue fever poses a significant public health threat in Brazil, leading to serious outbreaks and health complications.
  • This study examines maternal and fetal deaths linked to dengue, analyzing tissues from the placenta and umbilical cord using advanced molecular techniques.
  • The presence of dengue virus markers in these tissues suggests that they could serve as valuable tools in investigating fatal cases of dengue, particularly those affecting mothers and their unborn children.
View Article and Find Full Text PDF
Article Synopsis
  • The dengue virus non-structural 1 (NS1) protein is important for evading immune defenses and can be targeted for vaccine development due to its correlation with protective immunity.
  • In a study, BALB/c mice were vaccinated with a recombinant NS1 protein paired with various adjuvants, including LT(G33D), which resulted in a significant immune response and 50% protective immunity against dengue virus type 2 (DENV2).
  • Mice vaccinated with LT(G33D) showed stronger antibody responses along with fewer side effects compared to those vaccinated with Freund’s adjuvant, indicating a safer and more effective vaccine formulation.
View Article and Find Full Text PDF

The non-structural 1 (NS1) protein plays an important role in dengue diagnosis because it has been detected as a soluble serum antigen in both primary and secondary infections. The NS1 protein was expressed in Escherichia coli cells, and the efficiency of four different refolding protocols was tested. All of the protocols generated dimeric NS1 in a conformation similar to that of the protein expressed by eukaryotic cells.

View Article and Find Full Text PDF

The dengue virus NS1 protein has been shown to be a protective antigen under different experimental conditions but the recombinant protein produced in bacterial expression systems is usually not soluble and loses structural and immunological features of the native viral protein. In the present study, experimental conditions leading to purification and refolding of the recombinant dengue virus type 2 (DENV-2) NS1 protein expressed in Escherichia coli are described. The refolded recombinant protein was recovered as heat-stable soluble dimers with preserved structural features, as demonstrated by spectroscopic methods.

View Article and Find Full Text PDF

One difficulty in studying dengue virus (DENV) is the lack of an experimental model that reproduces the human disease. In a previous work, we have shown that BALB/c mice intraperitoneally inoculated with a DENV-2 isolate presented viremia and mild focal areas of liver injuries. In this study, mice were inoculated by the intravenous route and presented extensive damage areas in the liver tissue, which were evaluated by histopathological and ultrastructural analysis.

View Article and Find Full Text PDF